Additional Metadata
Persistent URL dx.doi.org/10.1016/j.jhep.2018.10.032, hdl.handle.net/1765/115183
Journal Journal of Hepatology
Citation
Boerekamps, A., Vanwolleghem, T., van der Valk, M, van den Berk, G.E., van Kasteren, M, Posthouwer, D, … Rijnders, B.J.A. (2019). 8 weeks of sofosbuvir/ledipasvir is effective in DAA-naive non-cirrhotic HCV genotype 4 infected patients (HEPNED-001 study). Journal of Hepatology, 70(3), 554–557. doi:10.1016/j.jhep.2018.10.032